A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living with small cell lung cancer (SCLC).

For 17 years, Ken Jones fought fires in San Francisco. Now, he is fighting cancer -- and the insurance company that insures ...

Uncertain about how you can stay healthy on a tight budget, especially when bombarded with misinformation from social media ...

Projected losses in Medicaid coverage as a result of President Trump's "One Big Beautiful Bill" could result in more than 1 million missed cancer screenings and hundreds of avoidable deaths within 2 ...

Had I known, I would have done this 20 years prior,' Lung cancer survivor shares her story about the importance of testing for radon ...

Chicago-based Northwestern Medicine has built one of the country’s most ambitious transplant programs. Whether performing the first double lung-liver transplant in the U.S., eliminating all traces of ...

The American Cancer Society supported five bills aimed at cancer prevention and treatment in 2025, but only one passed.

With most lung cancers in India diagnosed at advanced stages, experts say low-dose CT screening for high-risk groups like ...

Ali Mokdad led a global survey on cancer rates, finding that his native country of Lebanon is experiencing the fastest ...

The Dallas Cowboys boast a number of talented players across their storied history and one of them is the incredible Darren ...

Immuneering Corporation stays a Strong Buy: pancreatic cancer combo shows 64% 12‑mo OS, strong safety, and clear catalysts ...

How to lose weight in 2026 with the new Wegovy pill. Also in this month’s Your Health column: Is the super flu a real thing; ...